Join our daily newsletter At The Bell to receive exclusive market insights
- Healius (HLS) has collaborated with mining magnate Andrew Forrest and his Minderoo Foundation for COVID-19 testing
- Minderoo is purchasing 10 million coronavirus tests for the Australian public
- Healius CEO Dr Malcolm Parmenter said these tests will enable the company to dramatically lift its COVID-19 testing capacity
- The testing will be through Minderoo’s national Safety Through Accelerated Testing (STAT) program
- Healius is down a slight 0.40 per cent on market close, trading for $2.50 per share
Healius (HLS) has collaborated with the Minderoo Foundation for COVID-19 testing.
Mining magnate Andrew Forrest and his Minderoo Foundation will help expand COVID-19 tests across the country. Minderoo is purchasing 10 million coronavirus tests for the Australian public.
The testing will be through Minderoo’s national Saftey Through Accelerated Testing (STAT) program.
The new tests will help the healthcare company increase its own capacity for COVID-19 testing.
Healius CEO Dr Malcolm Parmenter said the company is able to dramatically lift its COVID-19 testing, therefore expanding its essential frontline services and helping Australians during this pandemic.
“Commencing next week, our capacity for COVID-19 testing through this program will ramp up,” he said.
“Collection from the public can occur through our dedicated COVID-19 collection centres and expanding footprint of drive-through facilities while rapid testing will be undertaken in our pathology laboratories under the expert guidance our microbiologists,” he added.
Malcolm said he is thankful for Andrew and Nicola Forrest, the Minderoo Foundation, the Federal Minister for Health, Greg Hunt, and the Australian Government for enabling Healius to be part of this great initiative.
“As the government prepares to lift lockdown restrictions, widespread testing will be a critical step in monitoring the health of the community in these dynamic times,” Malcolm said.
Healius is slightly down on market close, trading for $2.50 per share.
